A double-blind trial of 0-05% clobetasol proprionate in the treatment of vitiligo.
0-05% clobetasol proprionate (CP) in its proprietary cream base was significantly superior to the cream base alone in the treatment of vitiligo. Twelve of twenty-three patients partially repigmented during 4 months' treatment with CP. All patients showed dermal atrophy with the CP.